Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
Primary Purpose
Thoracic Insufficiency Syndrome
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Xenon-129
Sponsored by
About this trial
This is an interventional basic science trial for Thoracic Insufficiency Syndrome focused on measuring Hyperpolarized MRI, Dynamic Lung MRI
Eligibility Criteria
Inclusion Criteria:
- Males or females 6 to 18 years old diagnosed with thoracic insufficiency syndrome who are undergoing surgery
Exclusion Criteria:
- patients not diagnosed with thoracic insufficiency syndrome
Sites / Locations
- Children's Hospital of PhiladelphiaRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Thoracic Insufficiency Group
Arm Description
Thoracic insufficiency syndrome patients undergoing surgery
Outcomes
Primary Outcome Measures
Analyze volume of lungs at end-inspiration and end-expiration
Investigators will analyze lung volume at end-inspiration and end-expiration will be assessed by performing a thoracic dynamic magnetic resonance imaging scan; measured in total volume units (mL)
Xenon-129 MRI Ventilation Maps
Xenon-129 MRI will be completed to reveal unventilated regions of the lungs where the gas cannot reach after being inhaled due to restrictions of the airways.
Secondary Outcome Measures
oxygen partial pressure (PAO2) maps
Oxygen partial pressure (PAO2) maps will be extracted from 129Xe MRI maps in a single breath-hold. Regions of the lungs that show abnormal PAO2 values are susceptible of improper ventilation or gas exchange.
Forced vital capacity (FVC)
Forced vital capacity will be extracted from the computer-automated dynamic lung MRI software.
Forced expiratory volume (FEV1)
Forced expiratory volume data will be extracted from the computer-automated dynamic lung MRI software to assess the volume of air forced from the lungs
Xenon-129 MRI apparent diffusion coefficient (ADC) maps
Apparent diffusion coefficient (ADC) maps are extracted from the Xenon-129 MRI from a single breath-hold pulse sequence.
total lung capacity
Total lung capacity will be extracted from the computer-automated dynamic lung MRI software.
functional residual capacity (FRC)
functional residual capacity data will be extracted from the computer-automated dynamic lung MRI software to measure the volume in the lungs at the end of passive expiration
Full Information
NCT ID
NCT04977830
First Posted
July 14, 2021
Last Updated
April 11, 2023
Sponsor
Children's Hospital of Philadelphia
1. Study Identification
Unique Protocol Identification Number
NCT04977830
Brief Title
Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
Official Title
New Strategies for Pulmonary Assessment in Spinal and Chest Wall Deformity
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 2023 (Anticipated)
Primary Completion Date
August 30, 2024 (Anticipated)
Study Completion Date
August 30, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital of Philadelphia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
5. Study Description
Brief Summary
Thoracic insufficiency syndrome (TIS) is a complex condition that involves chest wall deformities that can affect normal breathing and lung growth. In most cases, children with TIS are also born with spine disorders such as scoliosis. The inability of the thorax to support normal respiration or lung growth can cause respiratory distress and even mortality. Investigators aim to validate MRI imaging sequences to use as an assessment tool for pulmonary function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thoracic Insufficiency Syndrome
Keywords
Hyperpolarized MRI, Dynamic Lung MRI
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Thoracic Insufficiency Group
Arm Type
Other
Arm Description
Thoracic insufficiency syndrome patients undergoing surgery
Intervention Type
Device
Intervention Name(s)
Xenon-129
Intervention Description
Patients will undergo a hyperpolarized MRI with administered Xenon gas
Primary Outcome Measure Information:
Title
Analyze volume of lungs at end-inspiration and end-expiration
Description
Investigators will analyze lung volume at end-inspiration and end-expiration will be assessed by performing a thoracic dynamic magnetic resonance imaging scan; measured in total volume units (mL)
Time Frame
up to 2 years
Title
Xenon-129 MRI Ventilation Maps
Description
Xenon-129 MRI will be completed to reveal unventilated regions of the lungs where the gas cannot reach after being inhaled due to restrictions of the airways.
Time Frame
up to 2 years
Secondary Outcome Measure Information:
Title
oxygen partial pressure (PAO2) maps
Description
Oxygen partial pressure (PAO2) maps will be extracted from 129Xe MRI maps in a single breath-hold. Regions of the lungs that show abnormal PAO2 values are susceptible of improper ventilation or gas exchange.
Time Frame
up to 2 years
Title
Forced vital capacity (FVC)
Description
Forced vital capacity will be extracted from the computer-automated dynamic lung MRI software.
Time Frame
up to 2 years
Title
Forced expiratory volume (FEV1)
Description
Forced expiratory volume data will be extracted from the computer-automated dynamic lung MRI software to assess the volume of air forced from the lungs
Time Frame
up to 2 years
Title
Xenon-129 MRI apparent diffusion coefficient (ADC) maps
Description
Apparent diffusion coefficient (ADC) maps are extracted from the Xenon-129 MRI from a single breath-hold pulse sequence.
Time Frame
up to 2 years
Title
total lung capacity
Description
Total lung capacity will be extracted from the computer-automated dynamic lung MRI software.
Time Frame
up to 2 years
Title
functional residual capacity (FRC)
Description
functional residual capacity data will be extracted from the computer-automated dynamic lung MRI software to measure the volume in the lungs at the end of passive expiration
Time Frame
up to 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Males or females 6 to 18 years old diagnosed with thoracic insufficiency syndrome who are undergoing surgery
Exclusion Criteria:
patients not diagnosed with thoracic insufficiency syndrome
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hamidou Keita
Phone
267-426-5433
Email
keitah@chop.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick Cahill, MD
Organizational Affiliation
Children's Hopsital of Philadelphia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital of Philadelphia
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hamidou Keita
Phone
267-426-5433
Email
keitah@chop.edu
First Name & Middle Initial & Last Name & Degree
Patrick Cahill, MD
12. IPD Sharing Statement
Learn more about this trial
Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
We'll reach out to this number within 24 hrs